heart palpitations with semaglutide reduces cardiovascular risk by 20 percent Semaglutide Heart Palpitations: Causes and
Description
Patients using fezolinetant require baseline and periodic liver function monitoring and should be counseled about symptoms of liver injury
M.-K., Sasako, M
Researchers with hypothyroidism frequently use tirzepatide successfully
Diarrhea impacts 8-12% of users with similar rates between medications
doi: 10.2337/dc22-S008 35 O'SullivanEDHughesJFerenbachDA
In a study by Probst et al., dulaglutide was given at a dose of 1.5 mg subcutaneously once weekly for 12 weeks
